Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKinsey
Baxter
Mallinckrodt
Boehringer Ingelheim

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Actavis Mid Atlantic Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-two approved drugs.



Summary for Actavis Mid Atlantic
US Patents:0
Tradenames:50
Ingredients:45
NDAs:62

Drugs and US Patents for Actavis Mid Atlantic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 204965-001 Nov 7, 2016 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Actavis Mid Atlantic FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride SOLUTION;ORAL 075690-001 Jan 31, 2002 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 074304-001 Aug 31, 1995 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Actavis Mid Atlantic TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 087798-001 Jun 4, 1982 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Actavis Mid Atlantic SELENIUM SULFIDE selenium sulfide LOTION/SHAMPOO;TOPICAL 084394-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Actavis Mid Atlantic CROMOLYN SODIUM cromolyn sodium SOLUTION;INHALATION 075067-001 Jul 19, 1999 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Johnson and Johnson
McKesson
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.